Pfizer Inc. recalls DOBUTamine Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Discoloration; discolored solution from cracked vials
- Products
-
- DOBUTamine Injection
- Company
- Pfizer Inc.
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 98,410 vials
- About this recall
- DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62